Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab Continued Past 24 Months Safely in MS
Disability in multiple sclerosis: A reference for patients and clinicians.
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
An unusual case of neurobrucellosis presenting as demyelination disorder.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
[Registries for neurological drugs landscape].
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Immunology: B-cell development in the gut.
Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
Similar genetics of adult and pediatric MS: Age is just a number.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
The formation of inflammatory demyelinated lesions in cerebral white matter.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Relevance of CD34+ Cells as a Reservoir for JC Virus in Patients With Multiple Sclerosis.
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
The possible efficacy of artichoke in fluconazole related hepatotoxicity.
Pages
« first
‹ previous
…
331
332
333
334
335
336
337
338
339
…
next ›
last »